Evidence map›Paper›PMID 30819554›Full record

ReviewKidney international2019

The (pro)renin receptor: an emerging player in hypertension and metabolic syndrome.

Nirupama Ramkumar, Donald E Kohan

Open access · bronzeAbstract readReview
In one paragraph

Review in Kidney international, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. The (pro)renin receptor as a pharmacological target in cardiorenal diseaes.Hypertension research : official journal of the Japanese Society of Hypertension · 2023
    Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. The HAmerican journal of physiology. Cell physiology · 2021
    Review
  16. Article
  17. Observational
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Nirupama RamkumarDivision of Nephrology, University of Utah Health Sciences Center, Salt Lake City, Utah, USA. Electronic address: Nirupama.ramkumar@hsc.utah.edu.
Donald E KohanDivision of Nephrology, University of Utah Health Sciences Center, Salt Lake City, Utah, USA; Salt Lake Veterans Affairs Medical Center, Salt Lake City, Utah, USA.
Salt Lake Regional Medical Center · USUniversity of Utah · US

Funding

Role of adenylyl cyclase isoforms in collecting duct physiology & pathophysiologyR01DK097007 · NIDDK · UNIVERSITY OF UTAH · PI KOHAN, DONALD E · 2013 to 2016
$1.3M
Collecting duct renin regulation of blood pressure in health and hypertensionI01BX002510 · VA · VA SALT LAKE CITY HEALTHCARE SYSTEM · PI KOHAN, DONALD E · 2015 to 2018
–
BLRD VA I01 BX002510NIDDK NIH HHS R01 DK097007
6 · The paper itself

Abstract

The (pro)renin receptor (PRR) is a multifunctional protein that is expressed in multiple organs. Binding of prorenin/renin to the PRR activates angiotensin II-dependent and angiotensin II-independent pathways. The PRR is also involved in autophagy and Wnt/ß catenin signaling, functions that are not contingent on prorenin binding. Emerging evidence suggests that the PRR plays an important role in blood pressure regulation and glucose and lipid metabolism. Herein, we review PRR function in health and disease, with particular emphasis on hypertension and the metabolic syndrome.

Indexed as

Angiotensin IIAnimalsAutophagyBlood PressureDisease Models, AnimalGlucoseHumansHypertensionLipid MetabolismMetabolic SyndromeProrenin ReceptorProton-Translocating ATPasesReceptors, Cell SurfaceReninRenin-Angiotensin SystemVacuolar Proton-Translocating ATPasesAngiotensin IIATP6AP2 protein, humanATP6AP2 protein, mouseGlucoseProrenin ReceptorProton-Translocating ATPasesReceptors, Cell SurfaceReninVacuolar Proton-Translocating ATPaseshypertensioninsulin resistanceobesity(pro)renin receptor

Identifiers

PMID30819554
PMCPMC6478511
OpenAlexW2917103516

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.